Fuji Pharma Co.,Ltd.

4554.TJapan

15 filed reports · 324 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

¥51.7B

FY2025 · to Sep 30, 2025

up +12.0% vs ¥46.1B

Half-year report

Net income

¥3B

FY2025 · to Sep 30, 2025

down −51.2% vs ¥6.15B

Annual report

Operating income

¥4.99B

FY2025 · to Sep 30, 2025

up +28.6% vs ¥3.88B

Annual report

Latest half year

Revenue

¥29.7B

H1 FY2026 · to Mar 31, 2026

up +23.3% vs ¥24.1B

Half-year report

Net income

¥713M

H1 FY2026 · to Mar 31, 2026

down −44.6% vs ¥1.29B

Half-year report

Operating income

¥4.4B

H1 FY2026 · to Mar 31, 2026

up +90.8% vs ¥2.31B

Half-year report

Filed reports

15 reports · Sep 2021 to Mar 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Annual · annual securities reportEDINET52,187Sep 2021 to Sep 2025
Q1 · quarterly securities reportEDINET3550Dec 2021 to Dec 2023
Half Year · half-year securities reportEDINET2539Mar 2025 to Mar 2026
Half Year · quarterly securities reportEDINET2448Mar 2022 to Mar 2024
Q3 · quarterly securities reportEDINET2382Jun 2022 to Jun 2023
Half Year · amended quarterly securities reportEDINET1221Mar 2023

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 H1half-year securities report2026-03-312026-05-13310Open
FY2025annual securities report2025-09-302025-12-18743Open
FY2025 H1half-year securities report2025-03-312025-05-09229Open
FY2024annual securities report2024-09-302024-12-23363Open
FY2024 H1quarterly securities report2024-03-312024-05-10224Open
FY2024 Q1quarterly securities report2023-12-312024-02-09212Open
FY2023annual securities report2023-09-302023-12-21347Open
FY2023 Q3quarterly securities report2023-06-302023-08-09211Open
FY2023 H1amended quarterly securities report2023-03-312023-05-18221Open
FY2023 Q1quarterly securities report2022-12-312023-02-10169Open
FY2022annual securities report2022-09-302022-12-21380Open
FY2022 Q3quarterly securities report2022-06-302022-08-08171Open

Financial data

324 concepts · 4,327 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

GAAP324 concepts · 4,327 facts · Sep 2019 to Mar 2026

  • EPS (Basic)44 · Sep 2019 to Mar 2026
  • Equity-to-asset ratio, Key financial data37 · Sep 2019 to Mar 2026
  • Net Assets37 · Sep 2019 to Mar 2026
  • Ordinary profit (loss), Key financial data37 · Sep 2019 to Mar 2026
  • Revenue37 · Sep 2019 to Mar 2026
  • Total Assets37 · Sep 2019 to Mar 2026
  • Net assets, Key financial data34 · Sep 2019 to Mar 2026
  • Accounts receivable - other32 · Sep 2020 to Mar 2026
  • Allowance for doubtful accounts-CA-by group32 · Sep 2020 to Mar 2026
  • Capital surplus32 · Sep 2020 to Mar 2026
  • Cash and deposits32 · Sep 2020 to Mar 2026
  • Construction in progress32 · Sep 2020 to Mar 2026
  • Current portion of long-term borrowings32 · Sep 2020 to Mar 2026
  • Deferred tax assets32 · Sep 2020 to Mar 2026
  • Income taxes payable32 · Sep 2020 to Mar 2026
  • Intangible assets32 · Sep 2020 to Mar 2026
  • Investments and other assets32 · Sep 2020 to Mar 2026
  • Investment securities32 · Sep 2020 to Mar 2026
  • Land32 · Sep 2020 to Mar 2026
  • Leased assets, net-PPE32 · Sep 2020 to Mar 2026
  • Lease liabilities - CL32 · Sep 2020 to Mar 2026
  • Lease liabilities - NCL32 · Sep 2020 to Mar 2026
  • Long-term advance payments32 · Sep 2020 to Mar 2026
  • Long-term borrowings32 · Sep 2020 to Mar 2026

Segments

Figures broken down by business line, region, product or another axis the company reports on.

No segment breakdowns.

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of Fuji Pharma Co.,Ltd. (4554.T) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.